US Industry Hauls Post-Brexit UK Over The Coals

IP Protections & Access To Innovation Seen As Weak Points

 
• By Ian Schofield
  
IP Protections & Access To Innovation Seen As Weak Points
The US pharma industry has flagged up issues around IP and market access in the UK • Source: Alamy

More from United Kingdom

More from Europe